Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Reproductive genetics scientist Hayashi

SUITA, Japan, July 31 Kyodo - Photo taken on Jan. 18, 2023, shows Osaka University Professor Katsuhiko Hayashi at a university campus in Suita, Osaka Prefecture. The reproductive genetics scientist's team succeeded in producing mice eggs using iPS cells. (Kyodo)

E

Sweden's day at Osaka expo

Kyoto University's Shinya Yamanaka, who won the Nobel Prize in physiology or medicine in 2012 for developing iPS cells, makes a speech at a ceremony in Osaka on May 14, 2025, marking the event's Sweden day.

E

World Exposition opens in Osaka

Visitors observe myocardial sheets created from iPS cells at Osaka Healthcare Pavilion on the opening day of the 2025 World Exposition in Osaka, western Japan, on April 13, 2025.

E

World's 1st transplant surgery using iPS cells conducted

KYOTO, Japan - Kyoto University professor Shinya Yamanaka holds a press conference in Kyoto on Sept. 12, 2014, after a Japanese research team transplanted retinal cells grown from induced pluripotent stem cells to a woman in her 70s earlier in the day, marking the first time iPS-derived cells have been introduced into a human body by surgery. Yamanaka developed iPS cells, a type of stem cells that can grow into various human body tissue.

E

World's 1st transplant surgery using iPS cells conducted

KOBE, Japan - Masayo Takahashi, researcher of the Riken Center for Developmental Biology, holds a press conference in Kobe, western Japan, on Sept. 12, 2014, after a Japanese research team led by Takahashi transplanted retinal cells grown from induced pluripotent stem cells to a woman in her 70s. It marked the first time iPS-derived cells have been introduced into a human body by surgery.

E

World's 1st transplant surgery using iPS cells conducted

KOBE, Japan - Masayo Takahashi, researcher of the Riken Center for Developmental Biology, smiles during a press conference in Kobe, western Japan, on Sept. 12, 2014, after a Japanese research team led by Takahashi transplanted retinal cells grown from induced pluripotent stem cells to a woman in her 70s. It marked the first time iPS-derived cells have been introduced into a human body by surgery.

E

World's 1st iPS cell transplant

OSAKA, Japan - Masayo Takahashi (L), project leader at Riken Center for Developmental Biology, inspects an experiment at Riken's stem cell culture laboratory in Kobe, western Japan, in February 2013. A Japanese team has recently conducted the world's first surgery to implant tissue derived from induced pluripotent stem cells into a human body as part of the clinical study led by Takahashi and others.

E

World's 1st iPS cell transplant

KOBE, Japan - The operation room of the Institute of Biomedical Research and Innovation Hospital in Kobe, western Japan, is seen on Sept. 10, 2014. The world's first surgery to implant retinal tissue derived from induced pluripotent stem cells into a human body was performed there in September 2014.

E

World's 1st transplant surgery using iPS cells conducted

KOBE, Japan - Photo taken Sept. 10, 2014, shows the Institute of Biomedical Research and Innovation Hospital in Kobe, western Japan. At the hospital on Sept. 12, a Japanese research team transplanted retinal cells grown from induced pluripotent stem cells to a woman in her 70s, marking the first time iPS-derived cells have been introduced into a human body by surgery.

E

Kyoto Univ. facility for platelet mass production

KYOTO, Japan - A clean room set up at Kyoto University Hospital's Clinical Research Center for Medical Equipment Development to produce large quantities of platelets for blood transfusions from induced pluripotent stem cells, also known as iPS cells, is shown to the media on March 17, 2014, a day before it officially begins operations.

E

Kyoto Univ. facility for platelet mass production

KYOTO, Japan - A clean room set up at Kyoto University Hospital's Clinical Research Center for Medical Equipment Development to produce large quantities of platelets for blood transfusions from induced pluripotent stem cells, also known as iPS cells, is shown to the media on March 17, 2014, a day before it officially begins operations.

E

Kyoto Univ.'s Yamanaka

KYOTO, Japan - Shinya Yamanaka (R), who heads Kyoto University's Center for iPS Cell Research and Application, apologizes during a press conference at the university in Kyoto on March 1, 2014, following revelations that the university's laboratory conducting experiments on induced pluripotent stem cells has been warned by the science ministry about its careless control of genetically engineered mice.

E

Kyoto Univ.'s Yamanaka

KYOTO, Japan - Shinya Yamanaka, who heads Kyoto University's Center for iPS Cell Research and Application, holds a press conference at the university in Kyoto on March 1, 2014, following revelations that the university's laboratory conducting experiments on induced pluripotent stem cells has been warned by the science ministry about its careless control of genetically engineered mice.

E

Kyoto Univ.'s Yamanaka

KYOTO, Japan - Shinya Yamanaka, who heads Kyoto University's Center for iPS Cell Research and Application, holds a press conference at the university in Kyoto on March 1, 2014, following revelations that the university's laboratory conducting experiments on induced pluripotent stem cells has been warned by the science ministry about its careless control of genetically engineered mice.

E

World's 1st iPS clinical research to begin

KOBE, Japan - Masayo Takahashi, project leader from the state-backed scientific research institute Riken, speaks at a news conference in Kobe, Hyogo Prefecture, on July 30, 2013. Riken and the Foundation for Biomedical Research and Innovation said that the world's first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina will begin on August 1, 2013.

E

World's 1st iPS clinical research to begin

KOBE, Japan - Masayo Takahashi (far L), project leader from the state-backed scientific research institute Riken, speaks at a news conference in Kobe, Hyogo Prefecture, on July 30, 2013. Riken and the Foundation for Biomedical Research and Innovation said that the world's first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina will begin on August 1, 2013.

E

World's 1st iPS clinical research to begin

KOBE, Japan - Masayo Takahashi, project leader from the state-backed scientific research institute Riken, speaks at a news conference in Kobe, Hyogo Prefecture, on July 30, 2013. Riken and the Foundation for Biomedical Research and Innovation said that the world's first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina will begin on August 1, 2013.

E

World's 1st iPS clinical research to begin

KOBE, Japan - Masayo Takahashi, project leader from the state-backed scientific research institute Riken, speaks at a news conference in Kobe, Hyogo Prefecture, on July 30, 2013. Riken and the Foundation for Biomedical Research and Innovation said that the world's first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina will begin on August 1, 2013.

E

World's 1st iPS clinical research to begin

KOBE, Japan - Masayo Takahashi (L), project leader from the state-backed scientific research institute Riken, speaks at a news conference in Kobe, Hyogo Prefecture, on July 30, 2013. Riken and the Foundation for Biomedical Research and Innovation said that the world's first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina will begin on August 1, 2013.

E

Clinical research using iPS cells approved

TOKYO, Japan - File photo taken in February 2013 shows Masayo Takahashi (2nd from L), an ophthalmologist who heads Riken's research team on retinal regeneration, and other researchers seeing an experiment on cultured stem cells in Kobe, Hyogo Prefecture. On June 26, 2013, a Japanese government panel approved a clinical research plan by the Riken governmental scientific research institute and the Foundation for Biomedical Research and Innovation to use human induced pluripotent stem cells, known as iPS cells, for regenerating retinas. It would be the world's first clinical research using iPS cells that can grow into any type of human body tissue.

E

Clinical research using iPS cells approved

TOKYO, Japan - Members of a health ministry panel hold a meeting in Tokyo on June 26, 2013, on whether to approve the world's first clinical research using human induced pluripotent stem cells, known as iPS cells, which can grow into any type of human tissue. The panel approved a clinical research plan by the Riken governmental scientific research institute and the Foundation for Biomedical Research and Innovation to use iPS cells for regenerating retinas.

E

Imperial garden party

TOKYO, Japan - Emperor Akihito (2nd from L in front) and Empress Michiko (L in front) exchange words with Kyoto University professor Shinya Yamanaka, who won the 2012 Nobel Prize in physiology or medicine for his advanced research on iPS cells, during a spring garden party at the Akasaka Imperial Garden in Tokyo on April 18, 2013.

E

Riken eyes iPS clinical research

KOBE, Japan - Masayo Takahashi (L), an ophthalmologist who heads Riken's research team on retinal regeneration at the Riken Center for Development Biology, speaks during a press conference in Kobe, western Japan, on Feb. 28, 2013. Riken, Japan's state-backed scientific research institute, applied for government permission the same day for its plan to conduct clinical research using induced pluripotent stem cells, known as iPS cells, to regenerate retina.

E

Riken eyes iPS clinical research

KOBE, Japan - Masayo Takahashi (L), an ophthalmologist who heads Riken's research team on retinal regeneration at the Riken Center for Development Biology, speaks during a press conference in Kobe, western Japan, on Feb. 28, 2013. Riken, Japan's state-backed scientific research institute, applied for government permission the same day for its plan to conduct clinical research using induced pluripotent stem cells, known as iPS cells, to regenerate retina.

E

Abe meets Nobel laureates

KOBE, Japan - Japanese Prime Minister Shinzo Abe (front) visits a laboratory belonging to Riken, a company that deals with the research of induced pluripotent stem cells in Kobe, western Japan, on Jan. 11, 2013. At left is Shinya Yamanaka, who won the 2012 Nobel Prize in medicine for the research of iPS cells. At center is Ryoji Noyori, Riken president and Nobel Prize in chemistry laureate. (Pool photo)

E

Nobel laureate visits minister

TOKYO, Japan - Kyoto University professor Shinya Yamanaka (L), a 2012 Nobel Prize in medicine laureate, visits education minister Hakubun Shimomura (R) at the ministry in Tokyo on Jan. 10, 2013. The minister pledged government support of 110 billion yen over 10 years for research on induced pluripotent stem cells, or iPS cells.

E

Prof. Yamanaka receives Balzan Prize for work on iPS cells

ROME, Italy - Shinya Yamanaka, professor at Kyoto University, holds up a certificate for the Balzan Prize in Rome on Nov. 19, 2010, after winning the award for his pioneering work in producing induced pluripotent stem cells, or iPS cells.

E

Professor Yamanaka receives Kyoto Prize

KYOTO, Japan - Shinya Yamanaka, a Kyoto University professor known for developing technologies to generate induced pluripotent stem cells, or iPS cells, receives a thread ball as a memento at the award ceremony in Kyoto on Nov. 10, 2010, for the 2010 Kyoto Prize, an international prize presented by the Inamori Foundation. Yamanaka was recognized for his contributions in the field of biotechnology and medical technology.

E

3 men receive Kyoto Prize

KYOTO, Japan - 2010 Kyoto Prize laureates (from L) Shinya Yamanaka, a Kyoto University professor known for developing technologies to generate induced pluripotent stem cells, or iPS cells, Hungarian mathematician Laszlo Lovasz and South African artist William Kentridge pose with the award at a press conference in Kyoto on Nov. 10, 2010. The international prize is annually presented by the Inamori Foundation to those who have made significant contributions in the field of advanced technology, basic sciences, as well as arts and philosophy.

E

Stem cell pioneer Yamanaka receives Kyoto award

KYOTO, Japan - Shinya Yamanaka (R), professor at Kyoto University's Institute for Integrated Cell-Material Sciences, receives the Kyoto Medal of Honor during a ceremony in the city Oct. 15, 2010 for his contribution in the field of induced pluripotent stem cells, or iPS cells.

E

Stem cell pioneer Yamanaka receives Kyoto Medal of Honor

KYOTO, Japan - Shinya Yamanaka, professor at Kyoto University, speaks about his joy in receiving the Kyoto Medal of Honor in the city Oct. 15, 2010. Yamanaka, who developed a technology to generate induced pluripotent stem cells, or iPS cells, said helping patients would be his way of returning the favor.

E

Emperor attends Japan Academy award ceremony

TOKYO, Japan - Emperor Akihito (L, back) and Empress Michiko (R, back) watch as Kyoto University professor Shinya Yamanaka (front) receives a Japan Academy award at the academy's hall in Tokyo on June 21, 2010. Yamanaka, who has conducted research on iPS cells that can develop into any type of body tissue, was one of 11 people to receive the awards this year.

E

Symposium on iPS held in Kyoto

KYOTO, Japan - A symposium on induced pluripotent stem cells, or iPS cells, which have the potential to grow into various kinds of body cells, was held in Kyoto on Dec. 25, with medical experts taking part.

E

Symposium on iPS held in Kyoto

KYOTO, Japan - Shinya Yamanaka, a professor at Kyoto University's Institute for Frontier Medical Sciences, gives a lecture at a symposium on induced pluripotent stem cells, or iPS cells, which have the potential to grow into various kinds of body cells, at a hotel in Kyoto on Dec. 25. Yamanaka is the world's first scientist to have created iPS cells.

E

Symposium on iPS held in Kyoto

KYOTO, Japan - Shinya Yamanaka, a professor at Kyoto University's Institute for Frontier Medical Sciences, gives a lecture at a symposium on induced pluripotent stem cells, or iPS cells, which have the potential to grow into various kinds of body cells, at a hotel in Kyoto on Dec. 25. Yamanaka is the world's first scientist to have created iPS cells. (Kyodo)

E

Symposium on iPS held in Kyoto

KYOTO, Japan - A symposium on induced pluripotent stem cells, or iPS cells, which have the potential to grow into various kinds of body cells, was held in Kyoto on Dec. 25, with medical experts taking part. (Kyodo)

E

Japanese research team to resume iPS cell transplants

Kyoto University professor Shinya Yamanaka, co-winner of the 2012 Nobel Prize in Medicine for his development of induced pluripotent stem cells, speaks at a press conference in the western Japan city of Kobe on June 6, 2016. Japan's government-backed Riken research institute said the same day that a research team including Yamanaka's Kyoto University will resume clinical tests to treat an eye disease by transplanting retinal cells grown from iPS cells. (Kyodo) ==Kyodo

E

Japanese research team to resume iPS cell transplants

Kyoto University professor Shinya Yamanaka (2nd from L), co-winner of the 2012 Nobel Prize in Medicine for his development of induced pluripotent stem cells, and Masayo Takahashi (3rd from L) of Japan's government-backed Riken research institute attend a press conference in the western Japan city of Kobe on June 6, 2016. The government announced the same day that a research team led by Takahashi, composed of Riken, Kyoto University and two other institutions, will resume clinical tests to treat an eye disease by transplanting retinal cells grown from iPS cells. (Kyodo) ==Kyodo

E

Kyoto Univ., Takeda launch joint research

Kyoto University Professor and Nobel laureate Shinya Yamanaka (L) shakes hands with Takeda Pharmaceutical Co. President Christophe Weber in Fujisawa, near Tokyo, on Dec. 15, 2015, after announcing that they have launched a joint research project to develop regenerative medicines using iPS cells. (Kyodo) ==Kyodo

E

Woman makes progress 1 year after world's 1st iPS cell transplant

Masayo Takahashi (R), a Riken researcher, holds a press conference in Kobe, western Japan, on Oct. 2, 2015, to announce that a woman in her 70s is making good progress in her eye disease treatment after the world's first transplant using iPS-derived cells a year ago. (Kyodo) ==Kyodo

E

Kyoto Univ. institute ties up with Takeda for iPS cell research

Takeda Pharmaceutical Co. President Christophe Weber (L) and Kyoto University professor and Nobel laureate Shinya Yamanaka shake hands after a joint press conference in Tokyo on April 17, 2015. Takeda and the university's iPS cell research institute will launch a 10-year, 20 billion yen joint program to realize regenerative medicine and drug discovery using iPS cells. (Kyodo) ==Kyodo

E

Nobel laureate Yamanaka speaks in interview

Shinya Yamanaka, co-winner of the 2012 Nobel Prize in Physiology and Medicine for his advanced research on induced pluripotent stems cells and head of the Center for iPS Cell Research and Application at Kyoto University, speaks to Kyodo News in Kyoto, western Japan, on March 26, 2015. Yamanaka said the center is undertaking studies to expand the application of iPS cells to more general medical treatments. (Kyodo) ==Kyodo

E

iPS-derived cells help recover rat's motor function

Osaka City University Hospital lecturer Takuya Uemura shows tubular "artificial nerves" at a press conference in Osaka, western Japan, on Feb. 20, 2015. A hospital team successfully recovered a rat's motor function after implanting in the rat about four million induced pluripotent stem (iPS) cells contained in such a body-absorbable artificial nerve structure. (Kyodo) ==Kyodo

E

iPS-derived cells help recover rat's motor funtion

Three types of "artificial nerves" developed by Osaka City University Hospital are shown in Osaka, western Japan, on Feb. 20, 2015. A hospital team successfully recovered a rat's motor function after implanting in the rat about four million induced pluripotent stem (iPS) cells contained in such a body-absorbable artificial nerve structure. (Kyodo) ==Kyodo

E

iPS-derived cells become part of rat's heart tissue, doctor says

Osaka University professor Yoshiki Sawa, a cardiovascular surgeon, reports at a press conference in Osaka, western Japan, on Jan. 25, 2015, that a cardiac muscle sheet of induced pluripotent stem (iPS) cells has assimilated with the heart tissue of a rat. (Kyodo) ==Kyodo

E

Japanese researcher hopes to lower cost of iPS cell transplant

Masayo Takahashi, a Riken institute project leader and member of the team that conducted the world's first transplant using iPS-derived cells in 2014, gives a talk at the Kansai Press Club in Osaka, western Japan, on Nov. 25, 2015. Takahashi said she hopes to find ways to lower the cost of such transplants and make them a standard treatment in the future. (Kyodo) ==Kyodo

E

Professor Yamanaka receives Kyoto Prize

KYOTO, Japan - Shinya Yamanaka, a Kyoto University professor known for developing technologies to generate induced pluripotent stem cells, or iPS cells, receives a thread ball as a memento at the award ceremony in Kyoto on Nov. 10, 2010, for the 2010 Kyoto Prize, an international prize presented by the Inamori Foundation. Yamanaka was recognized for his contributions in the field of biotechnology and medical technology. (Kyodo)

E

3 men receive Kyoto Prize

KYOTO, Japan - 2010 Kyoto Prize laureates (from L) Shinya Yamanaka, a Kyoto University professor known for developing technologies to generate induced pluripotent stem cells, or iPS cells, Hungarian mathematician Laszlo Lovasz and South African artist William Kentridge pose with the award at a press conference in Kyoto on Nov. 10, 2010. The international prize is annually presented by the Inamori Foundation to those who have made significant contributions in the field of advanced technology, basic sciences, as well as arts and philosophy. (Kyodo)

E

Stem cell pioneer Yamanaka receives Kyoto Medal of Honor

KYOTO, Japan - Shinya Yamanaka, professor at Kyoto University, speaks about his joy in receiving the Kyoto Medal of Honor in the city Oct. 15, 2010. Yamanaka, who developed a technology to generate induced pluripotent stem cells, or iPS cells, said helping patients would be his way of returning the favor. (Kyodo)

E

Stem cell pioneer Yamanaka receives Kyoto award

KYOTO, Japan - Shinya Yamanaka (R), professor at Kyoto University's Institute for Integrated Cell-Material Sciences, receives the Kyoto Medal of Honor during a ceremony in the city Oct. 15, 2010 for his contribution in the field of induced pluripotent stem cells, or iPS cells. (Kyodo)